Using world-leading glycobiology expertise to improve outcomes for patients
News
17. Dec
2020
Glycotope announces licensing agreement with ONK Therapeutics for humanized GlycoBody targeting TA-MUC1 GlycoBody to […]
21. Sep
2020
DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic […]